Experts Highlight Latest Advances in Immunotherapies for Hematologic Diseases

This series in the journal Blood outlines both current obstacles and new opportunities for the future on a selection of emerging immunotherapies now available to patients with hematologic diseases.

In the introduction to the series, Dr. Sophie Paczesny and colleagues illustrate how new immunotherapies use the patients’ own immune cells to kill cancer cells in a targeted way as compared to chemotherapies that indiscriminately kill quickly proliferating cells as well as healthy cells.

Articles in the series are: